HK1255728A1 - 利用抗il-23a抗體的哮喘治療 - Google Patents
利用抗il-23a抗體的哮喘治療Info
- Publication number
- HK1255728A1 HK1255728A1 HK18114879.7A HK18114879A HK1255728A1 HK 1255728 A1 HK1255728 A1 HK 1255728A1 HK 18114879 A HK18114879 A HK 18114879A HK 1255728 A1 HK1255728 A1 HK 1255728A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- asthma
- antibodies
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562147281P | 2015-04-14 | 2015-04-14 | |
US201562220385P | 2015-09-18 | 2015-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1255728A1 true HK1255728A1 (zh) | 2019-08-23 |
Family
ID=55911058
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103493.6A HK1243937A1 (zh) | 2015-04-14 | 2018-03-13 | 治療疾病的方法 |
HK18114879.7A HK1255728A1 (zh) | 2015-04-14 | 2018-03-13 | 利用抗il-23a抗體的哮喘治療 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103493.6A HK1243937A1 (zh) | 2015-04-14 | 2018-03-13 | 治療疾病的方法 |
Country Status (16)
Country | Link |
---|---|
US (4) | US20160304602A1 (zh) |
EP (3) | EP3283109A1 (zh) |
JP (1) | JP2018512422A (zh) |
KR (1) | KR20170135972A (zh) |
CN (1) | CN107530425A (zh) |
AU (1) | AU2016247921A1 (zh) |
BR (1) | BR112017018574A2 (zh) |
CA (1) | CA2977534A1 (zh) |
CL (1) | CL2017002304A1 (zh) |
EA (1) | EA201792282A1 (zh) |
HK (2) | HK1243937A1 (zh) |
IL (1) | IL253847A0 (zh) |
MX (1) | MX2017013156A (zh) |
PH (1) | PH12017501872A1 (zh) |
SG (1) | SG11201708399WA (zh) |
WO (1) | WO2016168282A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018135328A (ja) * | 2017-02-21 | 2018-08-30 | 地方独立行政法人青森県産業技術センター | TNFα産生抑制剤 |
CN113621558A (zh) * | 2021-09-08 | 2021-11-09 | 上海万何圆生物科技有限公司 | 一种新鲜肝组织切片的体外培养方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
ATE135397T1 (de) | 1988-09-23 | 1996-03-15 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
EP0752248B1 (en) | 1992-11-13 | 2000-09-27 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
TR201902033T4 (tr) | 2005-06-30 | 2019-03-21 | Janssen Biotech Inc | Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları. |
EA013506B1 (ru) | 2005-08-25 | 2010-06-30 | Эли Лилли Энд Компани | Антитело к il-23 и его применение |
US7807160B2 (en) | 2005-08-31 | 2010-10-05 | Schering Corporation | Engineered anti-IL-23 antibodies |
MX2008008621A (es) | 2005-12-29 | 2008-11-27 | Centocor Inc | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos. |
US7790862B2 (en) * | 2006-06-13 | 2010-09-07 | Zymogenetics, Inc. | IL-17 and IL-23 antagonists and methods of using the same |
HUE042172T2 (hu) | 2007-02-23 | 2019-06-28 | Merck Sharp & Dohme | Genetikailag elõállított anti-il-23P19 antitestek |
CA3017116A1 (en) * | 2010-11-04 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Anti-il-23 antibodies |
WO2012104402A1 (en) * | 2011-02-04 | 2012-08-09 | Ab Science | Treatment of severe persitent asthma with masitinib |
ES2908474T3 (es) * | 2012-05-03 | 2022-04-29 | Boehringer Ingelheim Int | Anticuerpos anti-IL-23p19 |
-
2016
- 2016-04-13 MX MX2017013156A patent/MX2017013156A/es unknown
- 2016-04-13 AU AU2016247921A patent/AU2016247921A1/en not_active Abandoned
- 2016-04-13 BR BR112017018574-1A patent/BR112017018574A2/pt not_active Application Discontinuation
- 2016-04-13 EA EA201792282A patent/EA201792282A1/ru unknown
- 2016-04-13 KR KR1020177033007A patent/KR20170135972A/ko unknown
- 2016-04-13 JP JP2017551277A patent/JP2018512422A/ja active Pending
- 2016-04-13 CN CN201680021688.9A patent/CN107530425A/zh active Pending
- 2016-04-13 EP EP16720609.3A patent/EP3283109A1/en not_active Withdrawn
- 2016-04-13 US US15/097,722 patent/US20160304602A1/en not_active Abandoned
- 2016-04-13 WO PCT/US2016/027263 patent/WO2016168282A1/en active Application Filing
- 2016-04-13 CA CA2977534A patent/CA2977534A1/en not_active Abandoned
- 2016-04-13 EP EP20156338.4A patent/EP3685856A1/en not_active Withdrawn
- 2016-04-13 SG SG11201708399WA patent/SG11201708399WA/en unknown
- 2016-04-13 EP EP18173790.9A patent/EP3391905A1/en not_active Withdrawn
-
2017
- 2017-08-06 IL IL253847A patent/IL253847A0/en unknown
- 2017-08-25 US US15/686,365 patent/US20180009887A1/en not_active Abandoned
- 2017-09-12 CL CL2017002304A patent/CL2017002304A1/es unknown
- 2017-10-13 PH PH12017501872A patent/PH12017501872A1/en unknown
-
2018
- 2018-03-13 HK HK18103493.6A patent/HK1243937A1/zh unknown
- 2018-03-13 HK HK18114879.7A patent/HK1255728A1/zh unknown
- 2018-06-27 US US16/019,670 patent/US20180334501A1/en not_active Abandoned
-
2019
- 2019-03-08 US US16/297,563 patent/US20190359701A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL253847A0 (en) | 2017-09-28 |
KR20170135972A (ko) | 2017-12-08 |
US20180334501A1 (en) | 2018-11-22 |
AU2016247921A1 (en) | 2017-08-31 |
HK1243937A1 (zh) | 2018-07-27 |
JP2018512422A (ja) | 2018-05-17 |
US20190359701A1 (en) | 2019-11-28 |
CL2017002304A1 (es) | 2018-05-18 |
PH12017501872A1 (en) | 2018-02-26 |
CN107530425A (zh) | 2018-01-02 |
EP3391905A1 (en) | 2018-10-24 |
CA2977534A1 (en) | 2016-10-20 |
EP3283109A1 (en) | 2018-02-21 |
MX2017013156A (es) | 2018-02-21 |
EA201792282A1 (ru) | 2018-04-30 |
EP3685856A1 (en) | 2020-07-29 |
SG11201708399WA (en) | 2017-11-29 |
US20160304602A1 (en) | 2016-10-20 |
US20180009887A1 (en) | 2018-01-11 |
BR112017018574A2 (pt) | 2018-04-17 |
WO2016168282A1 (en) | 2016-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304117A (en) | Anti-pvrig antibodies and methods of use | |
HK1258058A1 (zh) | 抗tigit抗體和使用方法 | |
HK1252858A1 (zh) | 抗cll-1抗體和使用方法 | |
HK1249445A1 (zh) | 抗分揀蛋白抗體和其使用方法 | |
IL259495A (en) | Antibodies and methods for using them | |
HK1252698A1 (zh) | 抗siglec-9抗體及其使用方法 | |
HK1252696A1 (zh) | 抗siglec-7抗體及其使用方法 | |
HK1254743A1 (zh) | 新穎抗密封蛋白抗體及使用方法 | |
IL270793A (en) | Anti-HTRA1 antibodies and methods of using them | |
HK1258850A1 (zh) | 抗tpbg抗體及使用方法 | |
HK1249866A1 (zh) | 用他塞利昔布進行治療的方法 | |
HK1255728A1 (zh) | 利用抗il-23a抗體的哮喘治療 |